In a report released on October 7, Yi Chen from H.C. Wainwright reiterated a Buy rating on Motus Gi Holdings (MOTS – Research Report), with a price target of $11.00. The company’s shares closed yesterday at $1.88.
According to TipRanks, Chen is an analyst with an average return of -22.9% and a 26.78% success rate. Chen covers the Healthcare sector, focusing on stocks such as Veru, Applied DNA Sciences, and Belite Bio, Inc. ADR.
Motus Gi Holdings has an analyst consensus of Strong Buy, with a price target consensus of $10.50.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $16.00 and a one-year low of $1.72. Currently, Motus Gi Holdings has an average volume of 1.13M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company was founded in September, 2016 and is headquartered in Fort Lauderdale, FL.
Read More on MOTS:
